Major Symposium About Vagus Nerve Stimulation & Depression at the American Psychiatric Association
A major symposium about vagus nerve stimulation as a treatment for chronic or recurrent depression will be presented at the American Psychiatric Association's Annual Meeting in May. This is the largest gathering of psychiatrists in the world and over 25,000 psychiatrists will be in attendance. On February 3, 2005, the FDA deemed vagus nerve stimulation(VNS Therapy) approvable as a treatment for chronic or recurrent treatment-resistant depression. The formal launch of VNS Therapy will take place at this meeting of the leading psychiatrists in the world. The manufacturer of the vagus nerve stimulator, Cyberonics Inc., will have a major symposium on the topic of VNS Therapy as a treatment for depression. VNS is not related to brain surgery or electroconvulsive therapy. There is no cognitive impairment( i.e. memory loss) or interactions with drugs. The sixty-minute procedure is usually performed in an out-patient hospital and the recovery process is less than five days. The book: Out of the Black Hole: The Patient's Guide to Vagus Nerve Stimulation and Depression will be exhibited at the American Psychiatric Association Annual Meeting in May. The book is available at www.VagusNerveStimulator.com, Amazon.com and Barnes & Noble.com.
It is written by a patient, who suffered from severe chronic depression and was implanted with the stimulator in the FDA investigational trial. The therapy completely changed his life. You can learn more at www.VagusNerveStimulator.com. There is a free electronic newsletter to keep you up-to-date. Charles Donovan was a patient in the FDA investigational trial of vagus nerve stimulation as a treatment for chronic or recurrent treatment-resistant depression. He was implanted with the vagus nerve stimulator in April of 2001. He chronicles his journey from the grips of depression thanks to vagus nerve stimulation therapy in his book: Out of the Black Hole: The Patient's Guide to Vagus Nerve Stimulation and Depression He is editor the http://www.VagusNerveStimulator.com Web Site
Related News
|
 |
|
|
RELATED ARTICLES
New FDA Approved Therapy for Depression: Timeline from Prescription to Procedure
On July 18, 2005, the U.S. Food and Drug Administration(FDA) approved vagus nerve stimulation as a treatment for chronic depression. On August 18th, I was a part of a conference call hosted by the manufacturer of the vagus nerve stimulator.
So You?ve Been Diagnosed with Bipolar Disorder?
If you've been diagnosed with bipolar disorder (also known as manic depression) you are not alone. It has been estimated that over 2 million people in the United States suffer from this form of mental illness which involves episodes of both mania and depression.
Depression in Teenagers: Now What Can We Do?
No doubt you have seen the recent news headlines about a federal panel that recommended to the FDA that anti-depressant medications carry the strongest possible warning label for use in children and teenagers. This recommendation to the FDA shook the medical community, especially those who work with depressed young people. The biggest problem from the treatment community's point of view was not the recommendation for the warning label, but the way that the media protrayed the panel's recommendation.
Depression: What It Is and What You Can Do About It
There are three basic ways to treat depression: psychotherapy, self-help, and medication. Many people respond best to a combination of two or more methods.
Major Depression and Its Serious Complications
When suffering from clinical depression, people have different ways of confronting it. Some acknowledge it, face it just like any problem, and seek help. Some ignore it as if it doesn't exist. And others simply accept that it's there but they don't do anything about it. In fact, they don't even ask for help.
Depression and EPA Fish Oil - Does It Really Work?
It is now no secret that people all over the western world are turning to high grade ethyl EPA omega 3 fish oil to treat a number of conditions, but can it really work against a problem that knows no boundaries of age, race or gender. It is a condition that affects millions of people at some time in there lives, it's called depression.
New Treatment for Depression to be Presented at the American Psychiatric Association Annual Meeting
Within the next few weeks, the FDA is expected to issue its final approval of a medical breakthrough treatment for chronic or treatment-resistant depression. This new therapy will be presented at the American Psychiatric Association's Annual Meeting in Atlanta from May 21st-May 25th. The Annual Meeting is the largest gathering of psychiatrists in the world. Over 25,000 psychiatrists are expected to attend this important medical meeting.
Depression is the Number One Cause of Disability in the United States
According to the World Health Organization, 4 of the 10 leading causes of disability in the United States and other developed countries are mental disorders, including major depression, bipolar disorder, and schizophrenia. Approximately 23% of American adults each year have a diagnosable mental disorder and as many as 5.4% of American adults have a serious mental illness.
Antidepressants 101- What You Absolutely Need to Know
Introduction
Andropause and Depression
Andropause correlates directly with depression ? a major player in the notorious mid-life crisis period men face in their late 40´s to late 50´s. There are a wide variety of symptoms and conditions hormone-wrecked men experience during this mid-life transition ? everything from the mental (i.e. irritability) to the physical (loss of libido, lack of energy, and weight gain.) Depression, left untreated, can be a disabling condition.
New Treatment for Depression to be FDA Approved by Late June
With the next few weeks, the FDA is expected to issue its final approval of vagus nerve stimulation as a treatment for chronic or recurrent depression. The approval of vagus nerve stimulation will be the first ever FDA approved long-term treatment option for the four million desperate Americans( and their families) who have not had an adequate response to traditional anti-depressants.
Aspartame and Your Mental Health
In 1965, a chemist working to develop an ulcer drug accidentally discovered a substance 200 times sweeter than sugar. The FDA initially shunned this substance because it caused seizures and brain tumors in lab animals.
Depression: 14 Universal Laws for Recovery
The Law of Blue
Depression Keeps 19 Million Adults From Being Productive
Approximately 19 million American adult workers allow depression to limit their productivity. According to the American Medical Women's Association, this includes 5 million women, many of whom will quit or loss their jobs directly due to the depression.
Senate Finance Committee Delays FDA Approval of Vagus Nerve Stimulation Therapy for Depression
On June 15th, 2004, FDA's Medical Devices Panel recommended that the U.S. Food and Drug Administration approve vagus nerve stimulation as a therapy for chronic or recurrent treatment-resistant depression. I was at the meeting, seated in the first row and made a presentation to the Panel.
Depression is Underdiagnosed in College Students
Everyone feels down or blue once in awhile. Especially during difficult times, it's normal to feel sad or discouraged. But when those feelings persist for two weeks or longer, it could be depression. It's a common illness that affects an estimated 19 million Americans-that's nearly one in ten! It's also one of the most under-diagnosed illnesses on college campuses. The symptoms can come on so slowly that one day, a person realizes that he can't remember the last time he felt good. Here are some warning signs for depression:
Insurance Reimbursement for Vagus Nerve Stimulation and Depression
I attended the Vagus Nerve Stimulation Therapy Conference at the manufacturers' (Cyberonics) headquarters in Houston, TX in late July. The Conference presenters included senior management, psychiatric thought leaders and study investigators from the investigational clinical trial. In this article , I will limit the discussion to the question that I am asked most often; will insurance companies or Medicare cover vagus nerve stimulation for depression?
Turn Depression into Joy
Depression is the most prevalent disease of our time. Under the guise of informing the public, both the medical profession and the media are constantly "warning" us of the dangers and probabilities of the disease most likely to terminate us. News about a lack of sufficient influenza vaccine is enough to get our collective blood pressure soaring.
Do Natural Stress, Anxiety, and Depression Supplements Really Work?
Unfortunately, millions of Americans currently suffer from the debilitating effects of stress, anxiety, and depression. In the pharmaceutical industry, anti-anxiety medications and antidepressants are among the best-selling medications on the market.
Anxiety and Depression - Why Depression Drugs May Not Be Necessary - Fight Depression Naturally
Millions of people, especially in the United States, are currently suffering the symptoms of depression, and have even gone as far as taking prescription antidepressants that may have harmful side effects and dampen the quality of their life in other ways in the hopes it will just go away.
|
